A top vaccine advisor at the FDA was forced to resign on Friday. In his resignation letter, Dr. Peter Marks, wrote "truth and ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Before joining Moderna, Cronin spent close to 20 years at Ogilvy, working within its global healthcare department in ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

As vaccine sentiment fluctuates and political scrutiny increases, Yale researchers weigh in on scientific transparency, ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

The shocking rise of aggressive cancers post-COVID-19 is prompting concerns from health experts about the long-term consequences of mRNA vaccines. One of the world's leading oncologists, Dr. Patrick ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $70.0 for Moderna over the recent three months. In terms of liquidity ...

We recently published a list of 10 Stocks To Trade Without Tariffs And Interest Rate Fears. In this article, we are going to ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.